Comprehensive HemeComplete Profile + Heme Fusion + CALR PCR + FLT3 PCR PathGroup United States | 16 | 160 | - T Targeted variant analysis
|
Myeloid NextGen Sequencing Assay with Calreticulin Exon 9 Mutation PathGroup United States | 16 | 65 | - T Targeted variant analysis
|
Myeloid NextGen Sequencing Assay PathGroup United States | 16 | 65 | - T Targeted variant analysis
|
Myeloid NextGen Sequencing Assay with FLT3 ITD and TKD Analysis PathGroup United States | 16 | 65 | - T Targeted variant analysis
|
Comprehensive Myeloid Profile + CALR PCR + FLT3 PCR PathGroup United States | 16 | 65 | - T Targeted variant analysis
|
Calreticulin Exon 9 Mutation, JAK2 V617F Quant and Exons 12-15 and MPL Mutation Analysis PathGroup United States | 9 | 3 | - T Targeted variant analysis
|
Calreticulin Exon 9 Mutation, MPL Mutation analysis and JAK2 Exons12-15 Mutation Analysis PathGroup United States | 9 | 3 | - T Targeted variant analysis
|
Calreticulin Exon 9 Mutation and MPL Mutation analysis PathGroup United States | 8 | 2 | - T Targeted variant analysis
|
Calreticulin Exon 9 Mutation and JAK2 V617F Quant and Exons 12-15 PathGroup United States | 8 | 2 | - T Targeted variant analysis
|
Calreticulin Exon 9 Mutation, MPL and JAK2 V617F Quant PathGroup United States | 9 | 3 | - T Targeted variant analysis
|
Calreticulin Exon 9 Mutation and JAK2 V617F Quant PathGroup United States | 8 | 2 | - T Targeted variant analysis
|
HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and T-Cell Clonality Analysis PathGroup United States | 23 | 160 | - T Targeted variant analysis
|
HemeComplete NextGen Sequencing Assay with Calreticulin Exon 9 Mutation, FLT3 ITD and TKD Analysis and JAK2 V617F Quant PathGroup United States | 18 | 160 | - T Targeted variant analysis
|
Calreticulin Exon 9 Mutation and FLT3 ITD and TKD Analysis PathGroup United States | 7 | 2 | - T Targeted variant analysis
|
Calreticulin Exon 9 Mutation and FLT3 ITD and TKD Analysis PathGroup United States | 7 | 2 | - T Targeted variant analysis
|
Calreticulin Exon 9 Mutation and FLT3 ITD and TKD Analysis PathGroup United States | 7 | 2 | - T Targeted variant analysis
|
BCR CML IS_expanded JAK2 +V617F quant_CALR_MPL PathGroup United States | 11 | 5 | - T Targeted variant analysis
|
BCR CML IS_JAK2_CALR_MPL PathGroup United States | 11 | 5 | - T Targeted variant analysis
|
BCR/ABL CML IS, CALR and JAK2 exon 12-15 (V617F Quant) PathGroup United States | 10 | 4 | - T Targeted variant analysis
|
Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1 IS PathGroup United States | 17 | 160 | - T Targeted variant analysis
|